Cargando…
PCD Advances Recommendations From First-Ever External Review
Autor principal: | Jack, Leonard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centers for Disease Control and Prevention
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6130284/ https://www.ncbi.nlm.nih.gov/pubmed/30191808 http://dx.doi.org/10.5888/pcd15.180414 |
Ejemplares similares
-
PCD Reflections on Progress and Successes Achieved in 2022
por: Jack, Leonard
Publicado: (2022) -
New for PCD in 2022: Increased Impact Factor, Expanded Expertise, First Guest Editorial Board, and Progress in Diversity, Equity, and Inclusion Goals
por: Jack, Leonard
Publicado: (2022) -
Challenges for Effective Glycemic control in T2DM during Covid-19 pandemic and Use of Glimepiride/Metformin FDC: Opinion from Indian Clinicians
por: Gandhi, Alka, et al.
Publicado: (2022) -
Another Year of Successes for PCD: Impact Factor, Collections, New Student Committee, Dr Lynne Wilcox Paper of the Year, and 2024 Calls for Papers
por: Jack, Leonard
Publicado: (2023) -
PCD Appoints New Experts and Releases Four Supplements in 2020 on COVID-19, CDC High Obesity Program, Public Health and Pharmacy, and Mental Health
por: Jack, Leonard
Publicado: (2020)